You have an idea you believe in. You can picture the product, the brand, maybe even the long-term vision. But when it comes ...
Chemours is reiterated as a 'Buy' with a $20 PT and fair value up to $30, reflecting cyclical upside and improved visibility. CC's Opteon refrigerants and Advanced Performance Materials segments are ...